Deprecated: mysql_connect(): The mysql extension is deprecated and will be removed in the future: use mysqli or PDO instead in /hsphere/local/home/prismadmin/nereenhealth.com/system/database/mysql.php on line 6
Adiceuticals: Peptides Identified Through AdiStem's Adult Adipose-Derived Stem Cell Research
Therapeutic and Regenerative Potential of Biomolecules from Adipose-derived Stem Cells
AdiStem has developed methods and apparatus to assist clinicians in using autologous blood (platelet rich plasma) and adult adipose-derived stem cells to address serious disease conditions. Importantly, the protocols devised for the procurement of adult adipose-derived stem cells do not overlook the therapeutic potential conferred by the cocktail of cells present in the stromal vascular fraction. Our research has involved utilising modern drug discovery techniques to connect the clinical benefits observed in autologous adipose-derived adult stem cell treatments to active biomolecules that are produced by the body in response to stem cell treatments. For example, utilising LC/MS/MS proteomics technology, one of the active protein (s) responsible for insulin resistance in Type II Diabetes patients involved in an adult adipose-derived stem cell clinical trial were identified. By deciphering the biomolecules responsible for adult adipose-derived stem cell clinical trial outcomes, AdiStem has identified several peptides with therapeutic potential.
Adistem is Developing Peptide Therapeutics
In 2010 AdiStem established a research and development base in Melbourne, Australia to exploit discoveries connected with its stem cell research. Specifically AdiStem Pty Ltd is developing several peptide therapeutics, which target a number of chronic diseases, including HIV/AIDS, Pain and Type II Diabetes. Peptides are fragments of proteins that play an important role in modulating many physiological processes and therefore have excellent potential as therapeutic agents. Peptides have a number of advantages over traditional drugs, including low toxicity and immunogenicity, excellent specificity and high potency. They now represent one of the most active areas of research and development in the drug discovery industry.
These peptides, identified through AdiStem’s adult adipose-derived stem cell research, are termed Adiceuticals (pharmaceuticals derived from adipose-derived stem cells). Adiceuticals Ltd., Hong Kong, is a wholly owned subsidiary of AdiStem Ltd.
“The AdiStem photoactivation technology facilitates less post injection discomfort and flare-ups with a more rapid recovery. This technology represents the next level in regenerative medicine providing a more customized approach to biologic based therapies like PRP.”
Dr. Steven Sampson, Founder of the Orthohealing Center, California, USA.
"Thanks for sharing with me this amazing product. I have been using it for the past 8 days and my skin tone is more homogenous and even. It is certainly brighter."
Dr. A. Allirani
“There’s no doubt the most exciting frontier in medicine now is adult stem cell therapy from fat. This is going to completely change the way patients are treated over the course of their lives and how we look at disease in the human body.”
Dr. Alvaro Skupin MD, FACP, FCCP, Owner of StemProcell, Florida, USA.
“Vasili Paspal Paris has had the most positive affect on my skin. It plumps and gives my face fullness I haven't had since my 20's... After every application my skin is simply left glowing, it is now my all-time favourite facial cream!”
Kellie Johns, The Price is Right Model/Australian Celebrity
"I love seeing the instant results with glowing tightened skin after using Vasili Paspal Paris. It helps me be picture perfect ready on the day of big events."
Tania Zaetta, Australian TV & Media Personality/Bollywood Actress